Insight

Latest California Healthline Stories

Safety Violations Compound Pain Of Painkiller Shortages

California and federal officials have cracked down on a major compounding pharmacy they say posed a threat to public safety, but their actions are worsening shortages of medications that doctors rely on to keep their patients out of pain.

Podcast: KHN’s ‘What The Health?’ It’s Nerd Week

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Sarah Kliff of Vox.com, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post discuss the Trump administration’s latest effort to revise rules for next year’s Affordable Care Act marketplaces. They also discuss state efforts to stabilize their individual markets in light of some of the changes being made at the federal level.

Medical Marijuana’s ‘Catch-22’: Federal Limits On Research Hinder Patients’ Relief

Suffering Americans seek medical marijuana as an alternative to opioids and other powerful pharmaceuticals. Though legal in 29 states, some doctors say the lack of strong data makes it hard to recommend. One researcher at the University of California-San Diego plans to use federally grown and controlled marijuana to study the effect of cannabidiol, a compound found in pot, on the neuropathic pain of HIV patients.

Video: A Conversation With FDA Commissioner Scott Gottlieb

Kaiser Health News reporter Sarah Jane Tribble sat down with Food and Drug Administration Commissioner Scott Gottlieb on C-SPAN’s “Newsmakers” program. The conversation ranged from how the nation should combat the opioid epidemic to reining in drug prices.